BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10665912)

  • 1. Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
    Schneider BG; Gulley ML; Eagan P; Bravo JC; Mera R; Geradts J
    Hum Pathol; 2000 Jan; 31(1):45-50. PubMed ID: 10665912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
    Vo QN; Geradts J; Gulley ML; Boudreau DA; Bravo JC; Schneider BG
    J Clin Pathol; 2002 Sep; 55(9):669-75. PubMed ID: 12194996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
    Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
    Han J; He D; Feng ZY; Ding YG; Shao CK
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
    Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
    Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
    Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.
    Harn HJ; Chang JY; Wang MW; Ho LI; Lee HS; Chiang JH; Lee WH
    Hum Pathol; 1995 Mar; 26(3):267-71. PubMed ID: 7890276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
    Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
    Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.
    Gulley ML; Pulitzer DR; Eagan PA; Schneider BG
    Hum Pathol; 1996 Jan; 27(1):20-7. PubMed ID: 8543306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
    Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
    Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
    Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
    Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
    Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
    Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
    Trimeche M; KsiĆ¢a F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-associated lymphoepithelioma-like gastric carcinoma in a patient with HIV.
    Kim J; Kim KM; Noh JH; Park CK
    Pathology; 2009; 41(6):593-5. PubMed ID: 19900113
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
    Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
    Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathology of Epstein-Barr virus-related gastric carcinoma].
    Itoh T; Tokunaga M
    Nihon Rinsho; 1997 Feb; 55(2):363-7. PubMed ID: 9046824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
    Vo QN; Geradts J; Boudreau DA; Bravo JC; Schneider BG
    Hum Pathol; 2002 Dec; 33(12):1200-4. PubMed ID: 12514789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.